Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
59 hedge funds and large institutions have $30.5M invested in Chembio diagnostics, Inc. in 2020 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 23 closing their positions.
29% more capital invested
Capital invested by funds: $23.7M → $30.5M (+$6.79M)
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
4% more call options, than puts
Call options by funds: $2.22M | Put options by funds: $2.13M
22% less funds holding
Funds holding: 76 → 59 (-17)
74% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$1.16M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$987K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$646K |
| 4 |
PM
Penbrook Management
New York
|
+$571K |
| 5 |
State Street
Boston,
Massachusetts
|
+$358K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.85M |
| 2 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$894K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$815K |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$648K |
| 5 |
RA
Royce & Associates
New York
|
-$440K |
CEMI Hedge Fund Activity: Q3 2020 in Review
59 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2020, worth a combined $30.5M — up 29% from $23.7M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of CEMI and 6 opened new positions — a net loss of 17 holders — while 19 trimmed existing stakes and 21 added.
The largest buyer was Segall Bryant & Hamill, adding an estimated $1.16M. The largest seller was Kennedy Capital Management, exiting entirely with an estimated $1.85M sold.
- 59 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2020, down from 76 in Q2 2020.
- Funds reported $30.5M of Chembio diagnostics, Inc. stock for Q3 2020, up 29% quarter-over-quarter.
- 6 funds opened new Chembio diagnostics, Inc. positions in Q3 2020 and 23 closed out, a net change of -17 holders.
- The largest Chembio diagnostics, Inc. buyer in Q3 2020 was Segall Bryant & Hamill, an estimated $1.16M added.
- The largest Chembio diagnostics, Inc. seller in Q3 2020 was Kennedy Capital Management, an estimated $1.85M sold.
Based on aggregated 13F filings for Q3 2020.